Operating Metrics 營運指標
Amgen Inc. (AMGN) Operating Metrics 營運指標
Amgen Inc. AMGN 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-03-31
最新營運指標
- Product Sales Volume Growth
- 9% · 2026-03-31 來源：Amgen Inc.
- Total Product Sales
- $35.493B · 2026-03-31 來源：Amgen Inc.、Amgen Inc.、Amgen Inc.、Amgen Inc.
- Repatha Sales
- $3,236M · 2026-03-31 來源：Amgen Inc.、Amgen Inc.、Amgen Inc.、Amgen Inc.
- EVENITY Sales
- $2,220M · 2026-03-31 來源：Amgen Inc.、Amgen Inc.、Amgen Inc.、Amgen Inc.
- Prolia Sales
- $4,042M · 2026-03-31 來源：Amgen Inc.、Amgen Inc.、Amgen Inc.、Amgen Inc.
- TEPEZZA Sales
- $2,012M · 2026-03-31 來源：Amgen Inc.、Amgen Inc.、Amgen Inc.、Amgen Inc.
- TEZSPIRE Sales
- $1,536M · 2026-03-31 來源：Amgen Inc.、Amgen Inc.、Amgen Inc.、Amgen Inc.
季度趨勢
| 指標 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 | Q2 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Product Sales Volume Growth | 9% | 10% | 14% | 13% | 14% | — | — | — |
| Total Product Sales | $8.218B | $9.367B | $9.137B | $8.771B | $7.873B | $8.716B | $8.151B | $8.041B |
| Repatha Sales | $876M | $870M | $794M | $696M | $656M | $606M | $567M | $532M |
| EVENITY Sales | $562M | $599M | $541M | $518M | $442M | $431M | $399M | $391M |
| Prolia Sales | $727M | $1,054M | $1,139M | $1,122M | $1,099M | $1,165M | $1,045M | $1,165M |
| TEPEZZA Sales | $490M | $457M | $560M | $505M | $381M | $460M | $488M | $479M |
| TEZSPIRE Sales | $343M | $474M | $377M | $342M | $285M | $296M | $269M | $234M |
資料來源
- Amgen Reports First Quarter 2026 Financial Results · Amgen Inc. · 2026-04-30
- Amgen Reports Fourth Quarter and Full Year 2025 Financial Results · Amgen Inc. · 2026-02-03
- Amgen Reports Third Quarter 2025 Financial Results · Amgen Inc. · 2025-11-04
- Amgen Reports Second Quarter 2025 Financial Results · Amgen Inc. · 2025-08-05